Pradhan Mantri Bhartiya Janaushadhi Kendras
Issued by Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals
Read or download the official PDF of this gazette notification issued by the Ministry of Chemicals and Fertilizers : Department of Pharmaceuticals on 11th August 2026. Classified under Press Release.
Executive Summary & Key Takeaways
Executive Summary This report details the progress and operational framework of the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) as of June 30, 2026. It highlights the establishment of 20,149 Jan Aushadhi Kendras (JAKs) nationwide, including 1,833 in Kerala, and outlines measures taken to ensure product quality, supply chain efficiency, and citizen savings totaling approximately ₹37,200 crore.
Key Points / Main Content
Scale and Reach
- As of June 30, 2026, 20,149 JAKs are operational across India, with a specific focus on Kerala, where 1,833 centers are distributed across 14 districts.
- The product basket includes 2,110 medicines and 315 surgicals/medical devices covering all major therapeutic groups, including anti-cancer, anti-diabetic, and cardiovascular drugs.
Economic Impact and Model
- Between FY 2021-22 and 2025-26, the scheme recorded sales of ₹7,873.85 crore, resulting in estimated savings of ₹37,200 crore for citizens.
- The scheme operates on a franchise-like model accessible to individual entrepreneurs, NGOs, trusts, and private companies via an online application process.
Supply Chain and Availability
- An IT-enabled supply chain connects five warehouses and 42 distributors nationwide.
- Since September 2024, JAK owners receive monthly incentives for maintaining stocks of 200 commonly used medicines (100 top-selling in the scheme and 100 fast-selling in the general market).
- The Pharmaceuticals and Medical Devices Bureau of India (PMBI) regularly monitors 400 fast-moving products and utilizes digital estimation for procurement.
Quality Assurance Mechanisms
- Medicines are procured exclusively from WHO-GMP certified manufacturers.
- Every batch undergoes 100% pre-testing at NABL-accredited laboratories compliant with Good Laboratory Practices (GLP) before dispatch to JAKs.
Impact Analysis
Citizens Impact Significant reduction in healthcare expenses, with cumulative savings of approximately ₹37,200 crore through access to affordable medicines and surgicals. Action Required Utilize local JAKs for therapeutic and surgical needs.
Entrepreneurs, NGOs, and Private Firms Impact Opportunity to operate a healthcare franchise under a government-supported model. Action Required Apply for opening new JAKs through the official website (www.janaushadhi.gov.in).
Jan Aushadhi Kendra (JAK) Owners Impact Eligible for monthly financial incentives based on inventory maintenance. Action Required Maintain consistent stocks of the 200 designated commonly used medicines to qualify for incentives.
District Administrations and Magistrates Impact Responsible for supporting the expansion of the scheme in underserved areas. Action Required Facilitate the provision of free space in government hospitals for applicants as requested by the PMBI.